ARTICLE | Company News
Affimed, J&J deal
July 22, 2013 7:00 AM UTC
Affimed's Amphivena Therapeutics Inc. subsidiary in the U.S. granted Johnson & Johnson's Janssen Biotech Inc. subsidiary an exclusive option to acquire Amphivena following an IND approval by FDA or ma...